Search Results - "Emiliani, Filippo"
-
1
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment
Published in Scientific reports (17-05-2024)“…We aimed to assess diagnostic accuracy of plasma p-tau181 and NfL separately and in combination in discriminating Subjective Cognitive Decline (SCD) and Mild…”
Get full text
Journal Article -
2
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol
Published in BMC neurology (12-08-2023)“…As disease-modifying therapies (DMTs) for Alzheimer's disease (AD) are becoming a reality, there is an urgent need to select cost-effective tools that can…”
Get full text
Journal Article -
3
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum?
Published in NeuroImage clinical (01-01-2023)“…•EEG reveals differences between prodromal stages of Alzheimer’s Disease.•Microstates analysis yield more inter-condition differences than spectral and network…”
Get full text
Journal Article -
4
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study
Published in Frontiers in psychiatry (11-03-2022)“…is a gene containing a key region of CAG repeats. When expanded beyond 39 repeats, Huntington disease (HD) develops. genes with <35 repeats are not associated…”
Get full text
Journal Article -
5
CAG repeats within the non-pathological range in the HTT gene influence personality traits in patients with Subjective Cognitive Decline (P11-3.004)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
6
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment
Published in Journal of the neurological sciences (15-10-2023)“…The aim of this study is to investigate the role of plasma phosphorylated tau (p-tau) 181 as a potential biomarker for Alzheimer's Disease (AD) pathology in…”
Get full text
Journal Article -
7
Subjective cognitive decline: 15 years of follow-up experience from a memory clinic (P7-6.005)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
8
Plasma neurofilament light chain predicts Alzheimer’s pathology and progression of cognitive decline in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study (P10-6.010)
Published in Neurology (25-04-2023)“…Abstract only…”
Get full text
Journal Article -
9
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study
Published in European journal of neurology (01-01-2024)“…Background and purpose We aimed to evaluate the accuracy of plasma neurofilament light chain (NfL) in predicting Alzheimer's disease (AD) and the progression…”
Get full text
Journal Article -
10
Huntingtin gene intermediate alleles influence the progression from Subjective Cognitive Decline to Mild Cognitive Impairment: a 15-year follow-up study (P18-3.003)
Published in Neurology (03-05-2022)“…Abstract only…”
Get full text
Journal Article -
11
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14‐year follow‐up study
Published in European journal of neurology (01-06-2022)“…Background and purpose Huntingtin (HTT) is a gene containing a key region of CAG repeats. HTT alleles containing from 27 to 35 CAG repeats are termed…”
Get full text
Journal Article -
12
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns
Published in Journal of the neurological sciences (15-05-2024)“…Mixed primary progressive aphasia (mPPA) accounts for a substantial proportion of primary progressive aphasia (PPA) cases. However, the lack of a standardised…”
Get full text
Journal Article -
13
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia
Published in Cortex (01-03-2024)“…Little is known about empathy changes from the early stages of Alzheimer's Disease (AD) continuum. The aim of this study is to investigate empathy across AD…”
Get full text
Journal Article -
14
-
15
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment
Published in Neurological sciences (01-03-2024)“… Introduction and aim NfL and GFAP are promising blood-based biomarkers for Alzheimer's disease. However, few studies have explored plasma GFAP in the…”
Get full text
Journal Article -
16
Plasma neurofilament light chain predicts Alzheimer’s disease in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study
Published in Alzheimer's & dementia (01-12-2023)“…Background Subjective cognitive decline (SCD) and mild cognitive impairment (MCI) represent a target population for early detection of Alzheimer’s Disease…”
Get full text
Journal Article -
17
A machine learning model to predict progression from subjective cognitive decline to mild cognitive impairment and dementia: a 12‐year follow‐up study
Published in Alzheimer's & dementia (01-12-2023)“…Background Subjective cognitive decline (SCD) represents a target population to be screened for dementia. Previous studies identified demographic, cognitive…”
Get full text
Journal Article -
18
Alzheimer’s Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus
Published in Journal of personalized medicine (06-06-2022)“…Patients with idiopathic normal pressure hydrocephalus (iNPH) frequently show pathologic CSF Aβ42 levels, comparable with Alzheimer’s Disease (AD)…”
Get full text
Journal Article